Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TERF1 pseudogene 6 (TERF1P6) is classified as a pseudogene—a genomic DNA sequence similar to the functional TERF1 gene, but which does not encode a functional protein product. Pseudogenes typically arise by duplication or retrotransposition and usually lack biological activity, regulatory roles, or therapeutic relevance. TERF1P6 is not considered a druggable target (receptor, enzyme, transporter) and there is currently no evidence for its involvement in disease, molecular activity, or use as a biomarker. The canonical *functional* gene in this family is TERF1 (telomeric repeat-binding factor 1), which is involved in the shelterin complex and telomere biology[1][3][5]. TERF1P6 has no known interactions with drugs, no mechanism of action, and no clinical associations. The listing of TERF1P6 as a therapeutic target is likely incorrect due to its pseudogene status.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TERF1 pseudogene 6 (TERF1P6).